{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:28:57Z","timestamp":1793316537115,"version":"4.5.0"},"reference-count":222,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.552925","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T12:02:55Z","timestamp":1600430575000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors\u2014The Current Status"],"prefix":"10.3389","volume":"11","author":[{"given":"Narasimha M.","family":"Beeraka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surya P.","family":"Sadhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SubbaRao V.","family":"Madhunapantula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeswara","family":"Rao Pragada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey A.","family":"Svistunov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir N.","family":"Nikolenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liudmila M.","family":"Mikhaleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gjumrakch","family":"Aliev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1126\/science.1087139","article-title":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China","volume":"302","author":"Guan","year":"2003","journal-title":"Science."},{"key":"B2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nm1001","article-title":"Pegylated interferon-\u03b1 protects type 1 pneumocytes against SARS coronavirus infection in macaques","volume":"10","author":"Haagmans","year":"2004","journal-title":"Nat Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1128\/MMBR.69.4.635-664.2005","article-title":"Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus","volume":"69","author":"Weiss","year":"2005","journal-title":"Microbiol Mol Biol Rev."},{"key":"B4","volume-title":"Features, Evaluation and Treatment Coronavirus (COVID-19)","author":"Cascella","year":"2020"},{"key":"B5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","article-title":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan","volume":"9","author":"Chan","year":"2020","journal-title":"Emerg Microbes Infect."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early transmission dynamics in Wuhan, China, of novel coronavirus\u2013infected pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"Ne Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1101\/2020.01.31.929042","article-title":"The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells","author":"Hoffmann","year":"2020","journal-title":"BioRxiv"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1007\/s00108-019-00671-5","article-title":"Coronaviruses as the cause of respiratory infections","volume":"60","author":"Corman","year":"2019","journal-title":"Der Internist"},{"key":"B9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1146\/annurev-med-051215-031152","article-title":"Middle East respiratory syndrome: emergence of a pathogenic human coronavirus","volume":"68","author":"Fehr","year":"2017","journal-title":"Ann Rev Med."},{"key":"B10","volume-title":"Laboratory Testing for Coronavirus Disease 2019 (COVID-19) in Suspected Human Cases: Interim Guidance","year":"2020"},{"key":"B11","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","article-title":"SARS and MERS: recent insights into emerging coronaviruses","volume":"14","author":"de Wit","year":"2016","journal-title":"Nat Rev Microbiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","article-title":"A novel coronavirus outbreak of global health concern","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202002.0220.v2","article-title":"Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer","author":"Tian","year":"2020","journal-title":"J Thorac Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1128\/JVI.03571-13","article-title":"Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2\u2032-O-methyltransferase activity","volume":"88","author":"Menachery","year":"2014","journal-title":"J Virol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.virol.2007.07.030","article-title":"Rat coronaviruses infect rat alveolar type I epithelial cells and induce expression of CXC chemokines","volume":"369","author":"Miura","year":"2007","journal-title":"Virol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1034\/j.1399-3003.1999.14a23.x","article-title":"IL-8 and neutrophil elastase levels in the respiratory tract of infants with RSV bronchiolitis","volume":"14","author":"Abu-Harb","year":"1999","journal-title":"Eur Respir J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"14933","DOI":"10.1128\/JVI.79.23.14933-14944.2005","article-title":"Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice","volume":"79","author":"Tumpey","year":"2005","journal-title":"J Virol."},{"key":"B18","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/00006454-199011000-00011","article-title":"The role of neutrophils in the pathogenesis of rhinovirus infections","volume":"9","author":"Turner","year":"1990","journal-title":"Pediatr Infect Dis J"},{"key":"B19","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1183\/09031936.98.12030612","article-title":"Neutrophils induce damage to respiratory epithelial cells infected with respiratory syncytial virus","volume":"12","author":"Wang","year":"1998","journal-title":"Eur Respir J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"9044","DOI":"10.1128\/JVI.75.19.9044-9058.2001","article-title":"Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays","volume":"75","author":"Zhang","year":"2001","journal-title":"J Virol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"L814","DOI":"10.1152\/ajplung.1997.273.4.L814","article-title":"Rhinovirus stimulation of interleukin-8 in vivo and in vitro: role of NF-\u03baB","volume":"273","author":"Zhu","year":"1997","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1615\/CritRevImmunol.v24.i3.40","article-title":"C and CX 3 C chemokines: cell sources and physiopathological implications","volume":"24","author":"Stievano","year":"2004","journal-title":"Crit Rev Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1165\/rcmb.2002-0227OC","article-title":"CXC chemokines and their receptors are expressed in type II cells and upregulated following lung injury","volume":"29","author":"Vanderbilt","year":"2003","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1476-9255-2-4","article-title":"CXCR2 is critical for dsRNA-induced lung injury: relevance to viral lung infection","volume":"2","author":"Londhe","year":"2005","journal-title":"J Inflamm."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1128\/JVI.80.6.2684-2693.2006","article-title":"Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro","volume":"80","author":"Yen","year":"2006","journal-title":"J Virol."},{"key":"B26","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00217.2020","volume-title":"COVID-19, ACE2 and the Cardiovascular Consequences","author":"South","year":"2020"},{"key":"B27","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature."},{"key":"B28","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus\u2013induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"7988","DOI":"10.1073\/pnas.0409465102","article-title":"Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry","volume":"102","author":"Hofmann","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"key":"B30","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/357420a0","article-title":"Human aminopeptidase N is a receptor for human coronavirus 229E","volume":"357","author":"Yeager","year":"1992","journal-title":"Nature."},{"key":"B31","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nm1024","article-title":"Identification of a new human coronavirus","volume":"10","author":"van der Hoek","year":"2004","journal-title":"Nat Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1099\/0022-1317-78-11-2795","article-title":"Identification of residues critical for the human coronavirus 229E receptor function of human aminopeptidase N","volume":"78","author":"Kolb","year":"1997","journal-title":"J Gen Virol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cub.2005.02.058","article-title":"The Nef protein of human immunodeficiency virus establishes superinfection immunity by a dual strategy to downregulate cell-surface CCR5 and CD4","volume":"15","author":"Michel","year":"2005","journal-title":"Curr Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2217\/fvl.10.4","article-title":"Renin\u2013angiotensin system in human coronavirus pathogenesis","volume":"5","author":"Wevers","year":"2010","journal-title":"Fut Virol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"7602","DOI":"10.4049\/jimmunol.173.12.7602","article-title":"Induction of IL-8 release in lung cells via activator protein-1 by recombinant baculovirus displaying severe acute respiratory syndrome-coronavirus spike proteins: identification of two functional regions","volume":"173","author":"Chang","year":"2004","journal-title":"J Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"20836","DOI":"10.1074\/jbc.M400759200","article-title":"Structural characterization of the SARS-coronavirus spike S fusion protein core","volume":"279","author":"Tripet","year":"2004","journal-title":"J Biol Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jmb.2006.09.074","article-title":"Mosaic structure of human coronavirus NL63, one thousand years of evolution","volume":"364","author":"Pyrc","year":"2006","journal-title":"J Mol Biol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.virol.2007.04.035","article-title":"The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2","volume":"367","author":"Li","year":"2007","journal-title":"Virology."},{"key":"B39","doi-asserted-by":"publisher","first-page":"19970","DOI":"10.1073\/pnas.0908837106","article-title":"Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor","volume":"106","author":"Wu","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B40","doi-asserted-by":"publisher","first-page":"7809","DOI":"10.1073\/pnas.0711241105","article-title":"Modulation of TNF-\u03b1-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-\u03b1 production and facilitates viral entry","volume":"105","author":"Haga","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1128\/JVI.01248-09","article-title":"Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63","volume":"84","author":"Glowacka","year":"2010","journal-title":"J Virol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"12658","DOI":"10.1128\/JVI.01542-10","article-title":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2","volume":"84","author":"Matsuyama","year":"2010","journal-title":"J Virol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"12552","DOI":"10.1128\/JVI.01890-13","article-title":"Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2","volume":"87","author":"Shirato","year":"2013","journal-title":"J Virol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"6150","DOI":"10.1128\/JVI.03372-12","article-title":"TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium","volume":"87","author":"Bertram","year":"2013","journal-title":"J Virol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"5502","DOI":"10.1128\/JVI.00128-13","article-title":"The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies","volume":"87","author":"Gierer","year":"2013","journal-title":"J Virol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e01815","DOI":"10.1128\/JVI.01815-18","article-title":"TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection","volume":"93","author":"Iwata-Yoshikawa","year":"2019","journal-title":"J Virol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"105933","DOI":"10.1016\/j.ijantimicag.2020.105933","article-title":"Arguments in favor of remdesivir for treating SARS-CoV-2 infections","volume":"55","author":"Ko","year":"2020","journal-title":"Int J Antimicrob Agents."},{"key":"B48","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet."},{"key":"B49","doi-asserted-by":"publisher","first-page":"8017","DOI":"10.1128\/JVI.00998-13","article-title":"Novel inhibitors of severe acute respiratory syndrome coronavirus entry that act by three distinct mechanisms","volume":"87","author":"Adedeji","year":"2013","journal-title":"J Virol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.antiviral.2006.10.008","article-title":"Inhibition of SARS-CoV replication cycle by small interference RNAs silencing specific SARS proteins, 7a\/7b, 3a\/3b and S","volume":"73","author":"\u00c5kerstr\u00f6m","year":"2007","journal-title":"Antiviral Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"16119","DOI":"10.1073\/pnas.0805240105","article-title":"A noncovalent class of papain-like protease\/deubiquitinase inhibitors blocks SARS virus replication","volume":"105","author":"Ratia","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"B52","doi-asserted-by":"publisher","first-page":"4968","DOI":"10.1021\/jm1004489","article-title":"Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, protein\u2013 ligand X-ray structure and biological evaluation","volume":"53","author":"Ghosh","year":"2010","journal-title":"J Med Chem."},{"key":"B53","doi-asserted-by":"publisher","first-page":"5684","DOI":"10.1016\/j.bmcl.2008.08.082","article-title":"Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors","volume":"18","author":"Ghosh","year":"2008","journal-title":"Bioorg Med Chem Lett."},{"key":"B54","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/protein\/gzn027","article-title":"Rapid discovery and optimization of therapeutic antibodies against emerging infectious diseases","volume":"21","author":"Rogers","year":"2008","journal-title":"Protein Eng Design Select."},{"key":"B55","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1165\/rcmb.2007-0217OC","article-title":"Amiodarone alters late endosomes and inhibits SARS coronavirus infection at a post-endosomal level","volume":"39","author":"Stadler","year":"2008","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B56","first-page":"9","article-title":"Antiviral activity of arbidol and its derivatives against the pathogen of severe acute respiratory syndrome in the cell cultures","volume":"53","author":"Khamitov","year":"2008","journal-title":"Voprosy Virusol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jep.2008.07.048","article-title":"Toona sinensis Roem tender leaf extract inhibits SARS coronavirus replication","volume":"120","author":"Chen","year":"2008","journal-title":"J Ethnopharmacol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3390\/molecules20010683","article-title":"Salvianolic acid Y: a new protector of PC12 cells against hydrogen peroxide-induced injury from Salvia officinalis","volume":"20","author":"Gong","year":"2015","journal-title":"Molecules."},{"key":"B59","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.antiviral.2009.12.001","article-title":"TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds","volume":"85","author":"Haga","year":"2010","journal-title":"Antiviral Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1177\/095632020601700505","article-title":"Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB\/c mice","volume":"17","author":"Barnard","year":"2006","journal-title":"Antiviral Chem Chemother."},{"key":"B61","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3851\/IMP1477","article-title":"Induction of interferon-\u03b3-inducible protein 10 by SARS-CoV infection, interferon alfacon 1 and interferon inducer in human bronchial epithelial Calu-3 cells and BALB\/c mice","volume":"20","author":"Kumaki","year":"2010","journal-title":"Antiviral Chem Chemother."},{"key":"B62","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1177\/135965350400900618","article-title":"Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons","volume":"9","author":"Scagnolari","year":"2004","journal-title":"Antivir Ther."},{"key":"B63","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.virol.2004.08.011","article-title":"Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV)","volume":"329","author":"Sainz","year":"2004","journal-title":"Virology."},{"key":"B64","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.20944\/preprints202003.0226.v1","article-title":"Potential inhibitor of COVID-19 main protease (Mpro) from several medicinal plant compounds by molecular docking study","volume":"1","author":"Khaerunnisa","year":"2020","journal-title":"Europe PMC."},{"key":"B66","unstructured":"Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation XuZ PengC ShiY ZhuZ MuK WangX 10.1101\/2020.01.27.921627.BioRxiv2020"},{"key":"B67","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.coviro.2014.06.002","article-title":"Antiviral drugs specific for coronaviruses in preclinical development","volume":"8","author":"Adedeji","year":"2014","journal-title":"Curr Opin Virol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1074\/jbc.C300520200","article-title":"A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2","volume":"279","author":"Wong","year":"2004","journal-title":"J Biol Chem."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","article-title":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease","volume":"395","author":"Richardson","year":"2020","journal-title":"Lancet."},{"key":"B70","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.antiviral.2007.10.011","article-title":"Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: involvement of p38 MAPK and ERK","volume":"77","author":"Kono","year":"2008","journal-title":"Antiviral Res."},{"key":"B71","doi-asserted-by":"publisher","first-page":"105932","DOI":"10.1016\/j.ijantimicag.2020.105932","article-title":"Chloroquine and hydroxychloroquine as available weapons to fight COVID-19","volume":"55","author":"Colson","year":"2020","journal-title":"Int J Antimicrob Agents."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1128\/AAC.03659-14","article-title":"Antiviral potential of ERK\/MAPK and PI3K\/AKT\/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis","volume":"59","author":"Kindrachuk","year":"2015","journal-title":"Antimicrobial Agents Chemother."},{"key":"B73","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1089\/dna.2017.4033","article-title":"Repurposing of kinase inhibitors as broad-spectrum antiviral drugs","volume":"37","author":"Schor","year":"2018","journal-title":"DNA Cell Biol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.1128\/AAC.03036-14","article-title":"Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection","volume":"58","author":"Dyall","year":"2014","journal-title":"Antimicrob Agents Chemother."},{"key":"B75","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1182\/blood.V87.6.2095.bloodjournal8762095","article-title":"Biologic basis for interleukin-1 in disease","volume":"87","author":"Dinarello","year":"1996","journal-title":"Blood."},{"key":"B76","first-page":"40","article-title":"Differences between anti-tumor necrosis factor-alpha monoclonal antibodies and soluble TNF receptors in host defense impairment","volume":"74","author":"Dinarello","year":"2005","journal-title":"J Rheumatol Suppl"},{"key":"B77","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nature13027","article-title":"Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430","volume":"508","author":"Warren","year":"2014","journal-title":"Nature."},{"key":"B78","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.cell.2014.03.033","article-title":"Designing defenses against deadly viruses","volume":"157","author":"Hiv","year":"2014","journal-title":"Cell"},{"key":"B79","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jiph.2016.04.002","article-title":"BCX4430\u2013a broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease","volume":"9","author":"Taylor","year":"2016","journal-title":"J Infect Public Health."},{"key":"B80","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4172\/1747-0862.1000029","article-title":"Host envelope glycoprotein processing proteases are indispensable for entry into human cells by seasonal and highly pathogenic avian influenza viruses","volume":"3","author":"Kido","year":"2009","journal-title":"J Mol Genet Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.pupt.2015.07.001","article-title":"The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells","volume":"33","author":"Yamaya","year":"2015","journal-title":"Pulmon Pharmacol Ther."},{"key":"B82","doi-asserted-by":"publisher","first-page":"e1003774","DOI":"10.1371\/journal.ppat.1003774","article-title":"Tmprss2 is essential for influenza H1N1 virus pathogenesis in mice","volume":"9","author":"Hatesuer","year":"2013","journal-title":"PLoS Pathog."},{"key":"B83","doi-asserted-by":"publisher","first-page":"4744","DOI":"10.1128\/JVI.03799-13","article-title":"TMPRSS2 is a host factor that is essential for pneumotropism and pathogenicity of H7N9 influenza A virus in mice","volume":"88","author":"Tarnow","year":"2014","journal-title":"J Virol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"5608","DOI":"10.1128\/JVI.03677-13","article-title":"The host protease TMPRSS2 plays a major role in in vivo replication of emerging H7N9 and seasonal influenza viruses","volume":"88","author":"Sakai","year":"2014","journal-title":"J Virol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"5154","DOI":"10.1128\/JVI.00124-15","article-title":"A mutant H3N2 influenza virus uses an alternative activation mechanism in TMPRSS2 knockout mice by loss of an oligosaccharide in the hemagglutinin stalk region","volume":"89","author":"Sakai","year":"2015","journal-title":"J Virol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"e35876","DOI":"10.1371\/journal.pone.0035876","article-title":"Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts","volume":"7","author":"Bertram","year":"2012","journal-title":"PLoS ONE."},{"key":"B87","doi-asserted-by":"publisher","first-page":"4122","DOI":"10.1128\/JVI.02232-10","article-title":"Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response","volume":"85","author":"Glowacka","year":"2011","journal-title":"J Virol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1128\/JVI.02202-13","article-title":"TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein","volume":"88","author":"Heurich","year":"2014","journal-title":"J Virol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.virol.2017.11.012","article-title":"Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry","volume":"517","author":"Shirato","year":"2018","journal-title":"Virology."},{"key":"B90","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1128\/JVI.02062-10","article-title":"A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry","volume":"85","author":"Shulla","year":"2011","journal-title":"J Virol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"13363","DOI":"10.1128\/JVI.05300-11","article-title":"Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease","volume":"85","author":"Bertram","year":"2011","journal-title":"J Virol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.antiviral.2013.09.028","article-title":"Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research","volume":"100","author":"Simmons","year":"2013","journal-title":"Antiviral Res."},{"key":"B93","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/path.1038","article-title":"VEGF and bFGF are highly expressed in intraluminal fibromyxoid lesions in bronchiolitis obliterans organizing pneumonia","volume":"196","author":"Lappi-Blanco","year":"2002","journal-title":"J Pathol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/path.4458","article-title":"Pathogenesis of Middle East respiratory syndrome coronavirus","volume":"235","author":"van den Brand","year":"2015","journal-title":"J Pathol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jcv.2004.03.003","article-title":"In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds","volume":"31","author":"Chen","year":"2004","journal-title":"J Clin Virol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(03)13973-6","article-title":"Treatment of SARS with human interferons","volume":"362","author":"Cinatl","year":"2003","journal-title":"Lancet."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1086\/382597","article-title":"Severe acute respiratory syndrome-related coronavirus is inhibited by interferon-\u03b1","volume":"189","author":"Str\u00f6her","year":"2004","journal-title":"J Infect Dis."},{"key":"B98","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1089\/1079990041535610","article-title":"Potent inhibition of SARS-associated coronavirus (SCOV) infection and replication by type I interferons (IFN-\u03b1\/\u03b2) but not by type II interferon (IFN-\u03b3)","volume":"24","author":"Zheng","year":"2004","journal-title":"J Interferon Cytok Res."},{"key":"B99","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1196\/annals.1408.002","article-title":"The molecular biology of SARS coronavirus","volume":"1102","author":"Satija","year":"2007","journal-title":"Ann N Y Acad Sci."},{"key":"B100","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.2174\/138161206779010459","article-title":"An overall picture of SARS coronavirus (SARS-CoV) genome-encoded major proteins: structures, functions and drug development","volume":"12","author":"Chen","year":"2006","journal-title":"Curr Pharma Design."},{"key":"B101","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s10565-006-0077-1","article-title":"M and N proteins of SARS coronavirus induce apoptosis in HPF cells","volume":"22","author":"Zhao","year":"2006","journal-title":"Cell Biol Toxicol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.abb.2007.01.012","article-title":"The SARS-Coronavirus Membrane protein induces apoptosis through modulating the Akt survival pathway","volume":"459","author":"Chan","year":"2007","journal-title":"Arch Biochem Biophys."},{"key":"B103","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1128\/JVI.02236-06","article-title":"Ribonucleocapsid formation of severe acute respiratory syndrome coronavirus through molecular action of the N-terminal domain of N protein","volume":"81","author":"Saikatendu","year":"2007","journal-title":"J Virol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.jmb.2007.02.069","article-title":"Structure of the SARS coronavirus nucleocapsid protein RNA-binding dimerization domain suggests a mechanism for helical packaging of viral RNA","volume":"368","author":"Chen","year":"2007","journal-title":"J Mol Biol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"7287","DOI":"10.1128\/JVI.00414-06","article-title":"Severe acute respiratory syndrome coronavirus 7a accessory protein is a viral structural protein","volume":"80","author":"Huang","year":"2006","journal-title":"J Virol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.virol.2005.10.015","article-title":"SARS coronavirus 7a protein blocks cell cycle progression at G0\/G1 phase via the cyclin D3\/pRb pathway","volume":"346","author":"Yuan","year":"2006","journal-title":"Virology."},{"key":"B107","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1743-422X-7-31","article-title":"SARS coronavirus protein 7a interacts with human Ap 4 A-hydrolase","volume":"7","author":"Vasilenko","year":"2010","journal-title":"Virol J."},{"key":"B108","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/nm1280","article-title":"Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque","volume":"11","author":"Li","year":"2005","journal-title":"Nat Med."},{"key":"B109","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/sj.gt.3302479","article-title":"siRNA targeting the leader sequence of SARS-CoV inhibits virus replication","volume":"12","author":"Li","year":"2005","journal-title":"Gene Ther."},{"key":"B110","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/sj.cr.7290286","article-title":"Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs","volume":"15","author":"Yi","year":"2005","journal-title":"Cell Res."},{"key":"B111","doi-asserted-by":"publisher","first-page":"7523","DOI":"10.1128\/JVI.78.14.7523-7527.2004","article-title":"Inhibition of severe acute respiratory syndrome virus replication by small interfering RNAs in mammalian cells","volume":"78","author":"Wang","year":"2004","journal-title":"J Virol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.antiviral.2004.09.005","article-title":"Inhibition of SARS-CoV replication by siRNA","volume":"65","author":"Wu","year":"2005","journal-title":"Antiviral Res."},{"key":"B113","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/135965350400900310","article-title":"Prophylactic and therapeutic effects of small interfering RNA targeting SARS coronavirus","volume":"9","author":"Zheng","year":"2004","journal-title":"Antiviral Ther."},{"key":"B114","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbrc.2005.05.095","article-title":"Screening of drugs by FRET analysis identifies inhibitors of SARS-CoV 3CL protease","volume":"333","author":"Liu","year":"2005","journal-title":"Biochem Biophys Res Commun."},{"key":"B115","doi-asserted-by":"publisher","first-page":"615","DOI":"10.2217\/fvl.11.33","article-title":"Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy","volume":"6","author":"Barnard","year":"2011","journal-title":"Fut Virol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/978-0-387-33012-9_5","article-title":"Deubiquitinating activity of the SARS-CoV papain-like protease","volume":"581","author":"Barretto","year":"2006","journal-title":"Nidoviruses"},{"key":"B117","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.abb.2007.07.006","article-title":"Selectivity in ISG15 and ubiquitin recognition by the SARS coronavirus papain-like protease","volume":"466","author":"Lindner","year":"2007","journal-title":"Arch Biochem Biophys."},{"key":"B118","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.2174\/138161206779010369","article-title":"Drug design targeting the main protease, the Achilles' heel of coronaviruses","volume":"12","author":"Yang","year":"2006","journal-title":"Curr Pharma Design."},{"key":"B119","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2174\/156802606776287090","article-title":"Characterization and inhibition of SARS-coronavirus main protease","volume":"6","author":"Liang","year":"2006","journal-title":"Curr Top Med Chem"},{"key":"B120","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1016\/j.febslet.2006.04.004","article-title":"Enzymatic activity of the SARS coronavirus main proteinase dimer","volume":"580","author":"Graziano","year":"2006","journal-title":"FEBS Lett."},{"key":"B121","doi-asserted-by":"publisher","first-page":"4933","DOI":"10.1038\/sj.emboj.7601368","article-title":"A second, non-canonical RNA-dependent RNA polymerase in SARS Coronavirus","volume":"25","author":"Imbert","year":"2006","journal-title":"Embo J."},{"key":"B122","doi-asserted-by":"publisher","first-page":"e1001176","DOI":"10.1371\/journal.ppat.1001176","article-title":"Zn2+ inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture","volume":"6","author":"Te Velthuis","year":"2010","journal-title":"PLoS Pathog."},{"key":"B123","doi-asserted-by":"publisher","first-page":"9977","DOI":"10.1128\/JVI.78.18.9977-9986.2004","article-title":"Identification and characterization of severe acute respiratory syndrome coronavirus replicase proteins","volume":"78","author":"Prentice","year":"2004","journal-title":"J Virol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.pep.2004.08.003","article-title":"Molecular cloning, expression, and purification of SARS-CoV nsp13","volume":"41","author":"Fan","year":"2005","journal-title":"Prot Exp Purif."},{"key":"B125","doi-asserted-by":"publisher","first-page":"5619","DOI":"10.1128\/JVI.78.11.5619-5632.2004","article-title":"Multiple enzymatic activities associated with severe acute respiratory syndrome coronavirus helicase","volume":"78","author":"Ivanov","year":"2004","journal-title":"J Virol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.1039\/b709515e","article-title":"Inhibition of SARS coronavirus helicase by bismuth complexes","author":"Yang","year":"2007","journal-title":"Chem Commun."},{"key":"B127","doi-asserted-by":"publisher","first-page":"6464","DOI":"10.1002\/anie.200701021","article-title":"Bismuth complexes inhibit the SARS coronavirus","volume":"46","author":"Yang","year":"2007","journal-title":"Angew Chem Int Ed."},{"key":"B128","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1016\/S0140-6736(04)16506-9","article-title":"Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets","volume":"363","author":"ter Meulen","year":"2004","journal-title":"Lancet."},{"key":"B129","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.antiviral.2010.11.007","article-title":"Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB\/c mouse model","volume":"89","author":"Kumaki","year":"2011","journal-title":"Antiviral Res"},{"key":"B130","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.bbrc.2008.04.006","article-title":"Interferon alfacon 1 inhibits SARS-CoV infection in human bronchial epithelial Calu-3 cells","volume":"371","author":"Kumaki","year":"2008","journal-title":"Biochem Biophys Res Commun."},{"key":"B131","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.virol.2009.09.023","article-title":"A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo","volume":"395","author":"Day","year":"2009","journal-title":"Virology"},{"key":"B132","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1479-5876-5-10","article-title":"Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models","volume":"5","author":"Zhu","year":"2007","journal-title":"J Transl Med."},{"key":"B133","doi-asserted-by":"publisher","first-page":"4444","DOI":"10.1128\/JVI.06635-11","article-title":"Nonstructural proteins 7 and 8 of feline coronavirus form a 2: 1 heterotrimer that exhibits primer-independent RNA polymerase activity","volume":"86","author":"Xiao","year":"2012","journal-title":"J Virol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s13238-010-0028-8","article-title":"New nsp8 isoform suggests mechanism for tuning viral RNA synthesis","volume":"1","author":"Li","year":"2010","journal-title":"Protein Cell."},{"key":"B135","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","volume":"14","author":"Gao","year":"2020","journal-title":"Biosci Trends"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir\u2013ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl J Med"},{"key":"B137","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41591-020-0820-9","article-title":"The proximal origin of SARS-CoV-2","volume":"26","author":"Andersen","year":"2020","journal-title":"Nat Med."},{"key":"B138","doi-asserted-by":"publisher","first-page":"e01774-19","DOI":"10.1128\/JVI.01774-19","article-title":"Trypsin treatment unlocks barrier for zoonotic bat coronavirus infection","volume":"94","author":"Menachery","year":"2020","journal-title":"J Virol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1086\/500469","article-title":"Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome","volume":"193","author":"Liu","year":"2006","journal-title":"J Infect Dis."},{"key":"B140","doi-asserted-by":"publisher","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"Vickers","year":"2002","journal-title":"J Biol Chem."},{"key":"B141","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1042\/BJ20040634","article-title":"Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism","volume":"383","author":"Rice","year":"2004","journal-title":"Biochem J."},{"key":"B142","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.tips.2004.04.001","article-title":"ACE2: from vasopeptidase to SARS virus receptor","volume":"25","author":"Turner","year":"2004","journal-title":"Trends Pharmacol Sci."},{"key":"B143","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1021\/ci0503614","article-title":"Structure-based pharmacophore design and virtual screening for novel angiotensin converting enzyme 2 inhibitors","volume":"46","author":"Rella","year":"2006","journal-title":"J Chem Inform Model."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.307708","article-title":"Role of the ACE2\/angiotensin 1\u20137 axis of the renin\u2013angiotensin system in heart failure","volume":"118","author":"Patel","year":"2016","journal-title":"Circ Res."},{"key":"B145","doi-asserted-by":"publisher","first-page":"39353","DOI":"10.1074\/jbc.M508914200","article-title":"Angiotensin-converting enzyme 2 (ACE2), but not ACE, is preferentially localized to the apical surface of polarized kidney cells","volume":"280","author":"Warner","year":"2005","journal-title":"J Biol Chem."},{"key":"B146","doi-asserted-by":"publisher","first-page":"e22682","DOI":"10.1371\/journal.pone.0022682","article-title":"ACE2-mediated reduction of oxidative stress in the central nervous system is associated with improvement of autonomic function","volume":"6","author":"Xia","year":"2011","journal-title":"PLoS ONE"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1101\/2020.02.06.20020974","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"18","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"B148","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s11427-020-1637-5","article-title":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","volume":"63","author":"Xu","year":"2020","journal-title":"Sci China Life Sci."},{"key":"B149","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/jtm\/taaa041","article-title":"Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19","author":"Diaz","year":"2020","journal-title":"J Travel Med."},{"key":"B150","doi-asserted-by":"publisher","first-page":"A20","DOI":"10.1016\/j.antiviral.2008.01.025","article-title":"Evaluation of interferon inducers, ribavirin and mouse hyperimmune serum in a pathogenesis\/lethal mouse model using a mouse-adapted SARS-CoV","volume":"2","author":"Barnard","year":"2008","journal-title":"Antiviral Res."},{"key":"B151","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.antiviral.2006.03.001","article-title":"Enhancement of the infectivity of SARS-CoV in BALB\/c mice by IMP dehydrogenase inhibitors, including ribavirin","volume":"71","author":"Barnard","year":"2006","journal-title":"Antiviral Res."},{"key":"B152","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.antiviral.2007.12.005","article-title":"Is the anti-psychotic, 10-(3-(dimethylamino) propyl) phenothiazine (promazine), a potential drug with which to treat SARS infections?","volume":"79","author":"Barnard","year":"2008","journal-title":"Antiviral Res."},{"key":"B153","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2172-6-2","article-title":"Expression profile of immune response genes in patients with severe acute respiratory syndrome","volume":"6","author":"Reghunathan","year":"2005","journal-title":"BMC Immunol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s41587-020-0577-1","article-title":"Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures","volume":"38","author":"Eroshenko","year":"2020","journal-title":"Nat Biotechnol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","article-title":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","volume":"39","author":"Channappanavar","year":"2017","journal-title":"Semin Immunopathol"},{"key":"B156","doi-asserted-by":"publisher","first-page":"e35421","DOI":"10.1371\/journal.pone.0035421","article-title":"Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus","volume":"7","author":"Tseng","year":"2012","journal-title":"PLoS ONE."},{"key":"B157","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1128\/JVI.79.4.2079-2086.2005","article-title":"Inhibition of beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3","volume":"79","author":"Spiegel","year":"2005","journal-title":"J Virol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1182\/blood-2004-10-4166","article-title":"Chemokine up-regulation in sars-coronavirus\u2013infected, monocyte-derived human dendritic cells","volume":"106","author":"Law","year":"2005","journal-title":"Blood."},{"key":"B159","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1042\/BJ20040984","article-title":"The SARS coronavirus nucleocapsid protein induces actin reorganization and apoptosis in COS-1 cells in the absence of growth factors","volume":"383","author":"Surjit","year":"2004","journal-title":"Biochem J."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1099\/vir.0.80813-0","article-title":"The 3a protein of severe acute respiratory syndrome-associated coronavirus induces apoptosis in Vero E6 cells","volume":"86","author":"Law","year":"2005","journal-title":"J General Virol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"14043","DOI":"10.1128\/JVI.78.24.14043-14047.2004","article-title":"Overexpression of 7a, a protein specifically encoded by the severe acute respiratory syndrome coronavirus, induces apoptosis via a caspase-dependent pathway","volume":"78","author":"Tan","year":"2004","journal-title":"J Virol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1743-422X-2-66","article-title":"G0\/G1 arrest and apoptosis induced by SARS-CoV 3b protein in transfected cells","volume":"2","author":"Yuan","year":"2005","journal-title":"Virol J."},{"key":"B163","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1086\/381535","article-title":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome","volume":"189","author":"Li","year":"2004","journal-title":"J Infect Dis."},{"key":"B164","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1084\/jem.20062545","article-title":"Selective blockade of the inhibitory Fc\u03b3 receptor (Fc\u03b3RIIB) in human dendritic cells and monocytes induces a type I interferon response program","volume":"204","author":"Dhodapkar","year":"2007","journal-title":"J Exp Med."},{"key":"B165","doi-asserted-by":"publisher","first-page":"12479","DOI":"10.1073\/pnas.1106568108","article-title":"Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection","volume":"108","author":"Chan","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B166","doi-asserted-by":"publisher","first-page":"674","DOI":"10.3389\/fimmu.2014.00674","article-title":"Immunomodulation by IVIg and the role of Fc-gamma receptors: classic mechanisms of action after all?","volume":"5","author":"Nagelkerke","year":"2015","journal-title":"Front Immunol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"6208067","DOI":"10.1155\/2018\/6208067","article-title":"Therapeutic modulation of virus-induced oxidative stress via the Nrf2-dependent antioxidative pathway","volume":"2018","author":"Lee","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"B168","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.4161\/hv.25813","article-title":"Oxidative stress induced by HIV-1 reverse transcriptase modulates the enzyme's performance in gene immunization","volume":"9","author":"Isaguliants","year":"2013","journal-title":"Hum Vaccines Immunother."},{"key":"B169","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.freeradbiomed.2008.05.004","article-title":"Thiol chemistry and specificity in redox signaling","volume":"45","author":"Winterbourn","year":"2008","journal-title":"Free Radic Biol Med."},{"key":"B170","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1164\/rccm.200804-535OC","article-title":"Antiviral activity of Nrf2 in a murine model of respiratory syncytial virus disease","volume":"179","author":"Cho","year":"2009","journal-title":"Am J Respir Crit Care Med."},{"key":"B171","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.virusres.2013.09.011","article-title":"Influenza A virus induction of oxidative stress and MMP-9 is associated with severe lung pathology in a mouse model","volume":"178","author":"Lee","year":"2013","journal-title":"Virus Res."},{"key":"B172","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1053\/gast.2002.30983","article-title":"Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein","volume":"122","author":"Okuda","year":"2002","journal-title":"Gastroenterology."},{"key":"B173","doi-asserted-by":"publisher","first-page":"e1004566","DOI":"10.1371\/journal.ppat.1004566","article-title":"Cellular oxidative stress response controls the antiviral and apoptotic programs in dengue virus-infected dendritic cells","volume":"10","author":"Olagnier","year":"2014","journal-title":"PLoS Pathog."},{"key":"B174","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.coi.2011.07.016","article-title":"The pathogenesis of influenza virus infections: the contributions of virus and host factors","volume":"23","author":"Fukuyama","year":"2011","journal-title":"Curr Opin Immunol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1164\/rccm.201010-1755OC","article-title":"Viral-mediated inhibition of antioxidant enzymes contributes to the pathogenesis of severe respiratory syncytial virus bronchiolitis","volume":"183","author":"Hosakote","year":"2011","journal-title":"Am J Respir Crit Care Med."},{"key":"B176","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.freeradbiomed.2017.10.380","article-title":"Respiratory syncytial virus induces NRF2 degradation through a promyelocytic leukemia protein-ring finger protein 4 dependent pathway","volume":"113","author":"Komaravelli","year":"2017","journal-title":"Free Radic Biol Med."},{"key":"B177","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1189\/jlb.4A0616-282RR","article-title":"HIV-1 decreases Nrf2\/ARE activity and phagocytic function in alveolar macrophages","volume":"102","author":"Staitieh","year":"2017","journal-title":"J Leukoc Biol."},{"key":"B178","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1128\/JVI.80.7.3273-3284.2006","article-title":"Astrocytes survive chronic infection and cytopathic effects of the ts1 mutant of the retrovirus Moloney murine leukemia virus by upregulation of antioxidant defenses","volume":"80","author":"Qiang","year":"2006","journal-title":"J Virol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"8941","DOI":"10.1074\/jbc.M110.186684","article-title":"Hepatitis C virus impairs the induction of cytoprotective Nrf2 target genes by delocalization of small Maf proteins","volume":"286","author":"Carvajal-Yepes","year":"2011","journal-title":"J Biol Chem."},{"key":"B180","doi-asserted-by":"publisher","first-page":"7199","DOI":"10.1128\/JVI.00321-06","article-title":"Hepatitis C virus triggers mitochondrial permeability transition with production of reactive oxygen species, leading to DNA damage and STAT3 activation","volume":"80","author":"Machida","year":"2006","journal-title":"J Virol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.freeradbiomed.2015.05.043","article-title":"Respiratory syncytial virus infection down-regulates antioxidant enzyme expression by triggering deacetylation-proteasomal degradation of Nrf2","volume":"88","author":"Komaravelli","year":"2015","journal-title":"Free Radic Biol Med."},{"key":"B182","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.1016\/j.jmb.2016.07.020","article-title":"Dimerization controls Marburg virus VP24-dependent modulation of host antioxidative stress responses","volume":"428","author":"Johnson","year":"2016","journal-title":"J Mol Biol."},{"key":"B183","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.celrep.2014.02.027","article-title":"Marburgvirus hijacks nrf2-dependent pathway by targeting nrf2-negative regulator keap1","volume":"6","author":"Page","year":"2014","journal-title":"Cell Rep."},{"key":"B184","doi-asserted-by":"publisher","first-page":"32000","DOI":"10.1038\/srep32000","article-title":"Activation of Nrf2 by the dengue virus causes an increase in CLEC5A, which enhances TNF-\u03b1 production by mononuclear phagocytes","volume":"6","author":"Cheng","year":"2016","journal-title":"Sci Rep."},{"key":"B185","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.freeradbiomed.2011.04.027","article-title":"Nrf2 expression modifies influenza A entry and replication in nasal epithelial cells","volume":"51","author":"Kesic","year":"2011","journal-title":"Free Radic Biol Med."},{"key":"B186","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1465-9921-13-43","article-title":"Nrf2 protects human alveolar epithelial cells against injury induced by influenza A virus","volume":"13","author":"Kosmider","year":"2012","journal-title":"Respir Res."},{"key":"B187","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1126\/science.1110656","article-title":"Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection","volume":"308","author":"Chandran","year":"2005","journal-title":"Science."},{"key":"B188","doi-asserted-by":"publisher","first-page":"11133","DOI":"10.1128\/JVI.00959-09","article-title":"Two-step conformational changes in a coronavirus envelope glycoprotein mediated by receptor binding and proteolysis","volume":"83","author":"Matsuyama","year":"2009","journal-title":"J Virol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1073\/pnas.0306446101","article-title":"Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry","volume":"101","author":"Simmons","year":"2004","journal-title":"Proc Natl Acad Sci USA."},{"key":"B190","doi-asserted-by":"publisher","first-page":"9896","DOI":"10.1128\/JVI.01118-06","article-title":"Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium","volume":"80","author":"B\u00f6ttcher","year":"2006","journal-title":"J Virol."},{"key":"B191","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1128\/JVI.80.9.4557-4569.2006","article-title":"Retrovirus-induced oxidative stress with neuroimmunodegeneration is suppressed by antioxidant treatment with a refined monosodium \u03b1-luminol (Galavit)","volume":"80","author":"Jiang","year":"2006","journal-title":"J Virol."},{"key":"B192","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.lfs.2012.03.013","article-title":"EGCG inhibits Tat-induced LTR transactivation: role of Nrf2, AKT, AMPK signaling pathway","volume":"90","author":"Zhang","year":"2012","journal-title":"Life Sci."},{"key":"B193","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1002\/jcp.24552","article-title":"Tanshinone II A inhibits tat-induced HIV-1 transactivation through redox-regulated AMPK\/Nampt pathway","volume":"229","author":"Zhang","year":"2014","journal-title":"J Cell Physiol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"L267","DOI":"10.1152\/ajplung.00288.2012","article-title":"Activating the Nrf2-mediated antioxidant response element restores barrier function in the alveolar epithelium of HIV-1 transgenic rats","volume":"305","author":"Fan","year":"2013","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"B195","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1080\/21505594.2017.1421893","article-title":"Lucidone suppresses dengue viral replication through the induction of heme oxygenase-1","volume":"9","author":"Chen","year":"2018","journal-title":"Virulence."},{"key":"B196","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1248\/bpb.32.1385","article-title":"Activity of andrographolide and its derivatives against influenza virus in vivo and in vitro","volume":"32","author":"Chen","year":"2009","journal-title":"Biol Pharma Bull."},{"key":"B197","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.taap.2014.07.010","article-title":"Celastrol ameliorates HIV-1 Tat-induced inflammatory responses via NF-kappaB and AP-1 inhibition and heme oxygenase-1 induction in astrocytes","volume":"280","author":"Youn","year":"2014","journal-title":"Toxicol Appl Pharmacol."},{"key":"B198","doi-asserted-by":"publisher","first-page":"e98671","DOI":"10.1371\/journal.pone.0098671","article-title":"Effect of broccoli sprouts on nasal response to live attenuated influenza virus in smokers: a randomized, double-blind study","volume":"9","author":"Noah","year":"2014","journal-title":"PLoS ONE."},{"key":"B199","doi-asserted-by":"publisher","first-page":"28001","DOI":"10.1074\/jbc.M115.669465","article-title":"Bakuchiol is a phenolic isoprenoid with novel enantiomer-selective anti-influenza A virus activity involving Nrf2 activation","volume":"290","author":"Shoji","year":"2015","journal-title":"J Biol Chem."},{"key":"B200","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.apsb.2017.05.006","article-title":"Chinese herbal medicine compound Yi-Zhi-Hao pellet inhibits replication of influenza virus infection through activation of heme oxygenase-1","volume":"7","author":"Yin","year":"2017","journal-title":"Acta Pharma Sin B."},{"key":"B201","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.intimp.2017.11.009","article-title":"Inhibition of curcumin on influenza A virus infection and influenzal pneumonia via oxidative stress, TLR2\/4, p38\/JNK MAPK and NF-\u03baB pathways","volume":"54","author":"Dai","year":"2018","journal-title":"Int Immunopharmacol."},{"key":"B202","doi-asserted-by":"publisher","first-page":"e79834","DOI":"10.1371\/journal.pone.0079834","article-title":"The spectral properties of (-)-epigallocatechin 3-O-gallate (EGCG) fluorescence in different solvents: Dependence on solvent polarity","volume":"8","author":"Snitsarev","year":"2013","journal-title":"PLoS ONE."},{"key":"B203","doi-asserted-by":"publisher","first-page":"9590","DOI":"10.1073\/pnas.1004104107","article-title":"Electrophilic tuning of the chemoprotective natural product sulforaphane","volume":"107","author":"Ahn","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B204","doi-asserted-by":"publisher","first-page":"285","DOI":"10.4103\/0973-1296.137369","article-title":"Pharmacokinetics and tissue distribution study of tanshinone IIA after oral administration of Bushen Huoxue Qubi granules to rats with blood stasis syndrome","volume":"10","author":"Wang","year":"2014","journal-title":"Pharmacogn Mag."},{"key":"B205","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fmed.2017.00069","article-title":"Celastrol: a spectrum of treatment opportunities in chronic diseases","volume":"4","author":"Casc\u00e3o","year":"2017","journal-title":"Front Med."},{"key":"B206","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ejps.2018.08.031","article-title":"The active compounds derived from Psoralea corylifolia for photochemotherapy against psoriasis-like lesions: the relationship between structure and percutaneous absorption","volume":"124","author":"Alalaiwe","year":"2018","journal-title":"Eur J Pharma Sci."},{"key":"B207","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ejmech.2014.02.029","article-title":"1, 2, 3-Triazole-containing derivatives of rupestonic acid: click-chemical synthesis and antiviral activities against influenza viruses","volume":"76","author":"He","year":"2014","journal-title":"Eur J Med Chem"},{"key":"B208","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jtcme.2016.05.005","article-title":"Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives\u2013a review","volume":"7","author":"Amalraj","year":"2017","journal-title":"J Tradit Complement Med."},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.13140\/RG.2.2.33764.12163G.2.2.33764.12163","article-title":"Potent NRF2-activating dietary supplements (like resveratrol, curcumin, sulforaphane, \u201cAsea redox supplement\u201d [ARS]) should be clinically tested as adjuvants in all types of medium and severe cases of aggressive respiratory viral infections (including Influenza A\/B\/C, SARS, MERS, COVID-19, measles, avian influenza etc.) based on their extrapolated cytoprotective antioxidant effects (especially on vital organs), including the cytoprotection offered by ARS on the cardiac muscle of DMD patients which can be extrapolated to the lungs - A very short medical communication","author":"Dr\u0103goi","year":"2019"},{"key":"B210","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet."},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202001.0358.v3","article-title":"Potential natural compounds for preventing 2019-nCoV infection","author":"Chen","year":"2020","journal-title":"Europe PMC [preprint]."},{"key":"B212","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.antiviral.2005.07.002","volume":"68","author":"Lin","year":"2005","journal-title":"Antiviral Res."},{"key":"B213","first-page":"1","article-title":"Citrus fruits are rich in flavonoids for immunoregulation and potential targeting ACE2","volume":"2020","author":"Cheng","year":"2020","journal-title":"Preprints"},{"key":"B214","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1021\/jm070295s","article-title":"Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus","volume":"50","author":"Wen","year":"2007","journal-title":"J Med Chem."},{"key":"B215","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1128\/JVI.02322-09","article-title":"Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae","volume":"84","author":"O'Keefe","year":"2010","journal-title":"J Virol."},{"key":"B216","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3109\/14756366.2012.753591","article-title":"Phenolic phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylifolia","volume":"29","author":"Kim","year":"2014","journal-title":"J Enzyme Inhibit Med Chem."},{"key":"B217","doi-asserted-by":"publisher","first-page":"5452","DOI":"10.1038\/srep05452","article-title":"Baicalin, a metabolite of baicalein with antiviral activity against dengue virus","volume":"4","author":"Moghaddam","year":"2014","journal-title":"Sci Rep."},{"key":"B218","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.3390\/molecules23123225","article-title":"Dual effect of glucuronidation of a Pyrogallol-type phytophenol antioxidant: a comparison between scutellarein and scutellarin","volume":"23","author":"Liu","year":"2018","journal-title":"Molecules."},{"key":"B219","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/0031-9422(82)83012-4","article-title":"Co-occurrence of nicotianamine and avenic acids in Avena sativa and Oryza sativa","volume":"21","author":"Fushiya","year":"1982","journal-title":"Phytochemistry"},{"key":"B220","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1016\/0031-9422(74)80243-8","article-title":"Azetidine-2-carboxylic acid derivatives from seeds of Fagus silvatica L. and a revised structure for nicotianamine","volume":"13","author":"Kristensen","year":"1974","journal-title":"Phytochemistry."},{"key":"B221","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s11101-019-09623-1","article-title":"Betulin and betulinic acid: triterpenoids derivatives with a powerful biological potential","volume":"18","author":"Hordyjewska","year":"2019","journal-title":"Phytochem Rev."},{"key":"B222","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1128\/AAC.00332-13","article-title":"The griffithsin dimer is required for high-potency inhibition of HIV-1: evidence for manipulation of the structure of gp120 as part of the griffithsin dimer mechanism","volume":"57","author":"Xue","year":"2013","journal-title":"Antimicrob Agents Chemother."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.552925\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T03:13:40Z","timestamp":1668827620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.552925\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,18]]},"references-count":222,"alternative-id":["10.3389\/fimmu.2020.552925"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.552925","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,18]]},"article-number":"552925"}}